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Abstract.  We have purified a polyclonal antibody by 
affinity chromatography which binds specifically to the 
phosphorylated form of the regulatory light chain (Mr 
=  20,000) of smooth muscle myosin. This antibody 
does not stain relaxed, permeabilized smooth muscle 
cells isolated from guinea pig taenia  coli.  However, 
when these cells were stimulated to contract with 
CaCI2  (100  ~tM) and ATP (1  mM), the immunofluores- 
cence staining was localized in a  series of transverse 
bands.  This distribution of activated myosin appears to 
reflect an underlying structural organization of the 
smooth muscle cell cytoskeleton into mechanically 
coupled contractile zones. 
UOOTH muscle has contractile properties which differ 
from those of striated muscle; in general, smooth mus- 
cle cells contract more slowly,  they can shorten to a 
much greater extent, and can maintain contraction with a 
smaller consumption of ATE However,  very little is known 
about the functional organization of the contractile compo- 
nents of these cells. Smooth muscle cells have no obvious di- 
rect equivalent of the striated muscle sarcomere, although 
actin and myosin filaments are aligned approximately in par- 
allel (4). A certain amount of  controversy has surrounded the 
stability of the myosin filaments in these cells.  Although 
myosin filaments have been detected in smooth muscle cells 
under both relaxed and contracting conditions (29), both in 
vitro (6) and in vivo (11, 12), data now indicate that the orga- 
nization of myosin in these cells may be dynamic, as it ap- 
pears to be in motile nonmuscle cells (22). At the biochemi- 
cal level, it is well established that phosphorylation of the 
20-kD regulatory myosin light chain (LC20) I both controls 
the  force-generating interaction of myosin with actin and 
promotes the self-assembly of myosin monomers to the fila- 
mentous form that is thought to be obligatory for contraction 
(1,  16, 23, 30, 32). 
As a result, one would expect the regions of contractile ac- 
tivity within a cell to contain phosphorylated myosin. Ac- 
cordingly, we have developed an antibody that specifically 
recognizes the phosphorylated form of myosin in order to 
identify contractile regions by immunofluorescence. In this 
paper we describe this antibody and its use to reveal the orga- 
nization of activated myosin in contracting smooth muscle 
cells. Our data suggest a new level of organization; the pres- 
ence of zones along the cell where phosphorylated myosin 
becomes concentrated during contraction. 
Materials and Methods 
Myosin light chain peptide 6-23 (kindly provided by Dr. B. Kemp, Univer- 
sity of Melbourne, Melbourne, Australia) was phosphorylated enzymically 
(16, 20) and the phosphopeptide purified on a CM52 column. Phosphopep- 
tide  was  coupled  to  keyhole  limpet  hemocyanin  (Calbiochem-Behring 
Corp., La Jolla, CA) at a mass ratio of 0.5:1  using 0.04%  glutaraldehyde 
in the presence of 0.1% SDS. The peptide, phosphopeptide, LC20, and thio- 
phosphorylated LC20 (prepared as in reference 16) were coupled to CNBr- 
activated Sepharose 4B  (Pharmacia  Fine  Chemicals,  Uppsala,  Sweden) 
using the manufacturer's recommended procedure. 
Antiserum was obtained from a  rabbit which had been immunized by 
subcutaneous injection of 200 p.g of the keyhole limpet hemocyanin-phos- 
phopeptide 6-23 conjugate in complete Freund's adjuvant (Difco Laborato- 
ries, Inc., Detroit,  MI) containing sodium pyrophosphate (20 mM) as a 
phosphatase inhibitor. The response was boosted with unconjugated phos- 
phopeptide 6-23  (50  I.tg) in  incomplete Freund's adjuvant and  sodium 
pyrophosphate (20 mM) at "~2-mo intervals. 
The crude antiserum was affinity  purified in four steps. (a) Serum was 
loaded  on  to  a  column  containing  phosphopeptide  6-23  coupled  to 
Sepharose, and washed with a column buffer consisting of 10 mM sodium 
phosphate buffer,  pH 7.0, 150 mM NaC1,  2  mM sodium pyrophosphate, 
5 mM NAN3. Bound antibody was removed with an elution buffer (0.2  M 
glycine buffer,  pH 2.7, 2 mM sodium pyrophosphate, 10 mM NAN3) and 
the eluate was immediately neutralized with Tris base. Fractions containing 
antibody to phosphopeptide  6-23 were identified by ELISA and pooled. (b) 
The eluted antibody was passed down a column containing peptide 6-23 
coupled to Sepharose. (c) Antibody that failed to bind was passed down a 
column containing LC20 coupled to Sepharose. (d) Antibody that failed to 
bind was loaded onto a column containing thiophosphorylated LC20 cou- 
pled to Sepharose, and washed with column buffer.  Material that bound to 
the column was washed off in elution buffer and immediately neutralized. 
Fractions containing antibody to phosphopeptide 6-23  were pooled and 
stored at  -20°C. 
Smooth muscle cells were isolated using a procedure based on reference 
25. Taenia coli muscles were dissected from a freshly killed guinea pig and 
immediately placed in a buffered salts solution (BSS) comprising 137 mM 
NaC1, 5 mM KCI, 20 mM Hepes buffer,  pH 7.4,  1 mM MgCI2,  1 mg/ml 
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strips were tied to pieces of plastic and digested with 1 mg/ml collagenase 
(type CLS II; Worthington Biochemical Corp., Freehold, NJ) for 45 min 
at 37°C in BSS containing 50 I~M CaCI2.  The muscles were rinsed in BSS 
containing 0.5 mM DTT but no added calcium, and finally given gentle me- 
chanical  disruption  in  BSS  containing 20  taM  EGTA.  Free  cells  were 
washed into BSS containing no serum albumin or trypsin inhibitor by gentle 
centrifugation (600 rpm for 3 min). 
Cells were stimulated to contract by adding an equal volume of a contrac- 
tion  solution containing 2  mM ATP,  0.2  mM CaCI2,  and 0.2%  Triton 
X-100 in BSS (modified as indicated for the experiments of Tables I and II). 
These cells typically shortened to between 25 and 40%  of their starting 
length, with a t,,~ for contraction of 30-60 s at 20°C. Contraction was ter- 
minated by rapidly fixing the slide with 3.7%  formaldehyde in  150  mM 
NaCI, 2 mM sodium pyrophosphate, 10 mM sodium phosphate buffer, pH 
7.0. After 2-5 min, each slide was transferred for overnight fixation at 4°C 
to a solution containing 0.05% glutaraldehyde in 150 mM NaCI, 2 mM so- 
dium pyrophosphate,  10 mM sodium citrate buffer, pH 5.0 (the low pH 
prevented LC20 from being lost before being cross-linked into the myosin). 
The cells were treated with 0.2% Triton X-100 for 5 min, then given three 
successive incubations in freshly prepared  10 mM NaBH4 (34).  Indirect 
immunofluorescence  labeling (33) was carried out in 150 mM NaCI, 2 mM 
sodium pyrophosphate, 10 mM sodium phosphate buffer, pH 7.0, 10 mg/ml 
BSA.  The affinity-purified antiserum was used at a  concentration of 80 
ng/ml protein, with a fluorescein-conjugated secondary antibody. Monoclo- 
nal antibody BM3 to myosin heavy chain has been previously described (5) 
and was used with a  rhodamine-conjugated secondary antibody. 
Measurement of antibody reactivity by EL1SA was carried out according 
to reference 15 using microtiter plates coated with antigen at "~25  pmol/ 
well. A peroxidase-coupled secondary antibody was used. 
PAGE in the presence of SDS was carried out according to reference 18. 
Transfer of proteins to nitrocellulose was carried out electrophoretically 
(31). The nitrocellulose blot was fixed for 10 min with 2.5 % gtutaraldehyde, 
rinsed, and incubated with 50 mM NaBH4 to reduce unreacted aldehyde 
groups  (LC20  is  extremely  soluble,  and  was  slowly  leached  from the 
nitrocellulose if not fixed). Antibody incubation and washes were carried 
out in 150 mM NaCI, 2 mM sodium pyrophosphate, 10 mM sodium phos- 
phate buffer, pH 7.0, 0.05% Tween 20, and a peroxidase-coupled second an- 
tibody was used. Parallel strips of nitrocellulose were stained for protein 
using Amido black. 
Results 
The affinity-purified  antibody raised against phosphopeptide 
6-23 bound to both phosphorylated peptide 6-23 and phos- 
Table I. The Effect of  Nucleotides on Myosin Light Chain 
Phosphorylation,  Detected by Immunofluorescence 
Condition  Experiment 1  Experiment 2  Experiment 3 
ATP*  100  100  100 
ATP)'S  98  76  87 
AMP-PNP  13  17  15 
ADP  17  18  - 
No nucleotide  11  34  29 
ATP  +  20  txM cAMP  85  93  96 
ATP  +  2  mM EGTA  2  0  0 
smooth muscle cells were treated with nucleotide at a final concentration of 
I mM (unless shown otherwise) in the presence of 0.1  mM CaCl2 and 0.1% 
Triton X-100, and the proportion of cells showing immunofluorescence  due to 
the antibody to phosphorylated LC20 was determined. On each slide, morpho- 
logically intact smooth muscle cells were identified using phase-contrast optics, 
and then scored for antibody staining after switching to epifluorescence illumi- 
nation.  For each condition t>200 cells were examined. The nucleotide  ana- 
logues used were adenosine-5'-O-(3-thiotriphosphate) (ATPyS) and adenylyl- 
imidodiphosphate (AMP-PNP). 
* For ease of comparison between  experiments, the results using ATP are nor- 
malized to a value of 100; the actual  results obtained were as follows: experi- 
ment 1,  150 positives from 282 cells examined; experiment 2,225 from 549; 
and experiment 3, 227 from 435. 
Table II. The Effect of Calcium Ion Concentration 
on the Phosphorylation of  Myosin Light Chain, 
Detected by lmmunofluorescence 
Condition  Result 
100  p.M Ca  2+  100" 
1 taM Ca  2÷  79 
50 nM Ca  2+  6 
<5  nM Ca  2+  0 
100  taM Ca  2+  +  10  I.tM trifluoperazine  49 
100  taM Ca  2÷  +  100  taM trifluoperazine  24 
Smooth muscle cells were treated with Ca  2+ and trifluoperazine  at the concen- 
trations shown in the presence of I mM ATP and 0. 1% Triton X-100. The low- 
er calcium ion concentrations were obtained using EGTA-CaCI2 buffers (14) 
at 2 mM. 
* The proportion of cells showing immunofluorescence was normalized as in 
Table I, with the reference condition corresponding to 227 cells staining out 
of 435 examined. 
phorylated myosin but not to unphosphorylated antigen (Fig. 
1). In other experiments (not shown), the antibody showed 
a similar specificity for the phosphorylated form of the iso- 
lated LC20 by ELISA, and stained only the bands corre- 
sponding to phosphorylated LC20 on a nitrocellulose blot of 
a  urea-glycerol gel (21) of phosphorylated myosin. The anti- 
body bound to a  single protein band that comigrated with 
LC20 in samples of contracted smooth muscle cells analyzed 
by SDS-PAGE  (Fig. 2). 
The antibody specific for phosphorylated LC20 stains iso- 
lated smooth muscle cells from guinea pig taenia coli that 
have  been  permeabilized  and  induced  to  contract  with 
CaC12 and ATP (Fig. 3).  Typically, m50-60%  of the cells 
in any preparation responded to this contracting solution and 
stained with the antibody. Smooth muscle cells that failed to 
contract did not stain with the antibody; neither did unstimu- 
lated cells. All cells, whether or not they contracted, con- 
rained myosin as detected using antibody BM3 (5), which is 
a  monoclonal  antibody  that  reacts  against  the  COOH- 
terminal end of nonmuscle or smooth muscle myosin heavy 
chains. 
Immunofluorescence  of  stimulated  cells  followed  the 
known ability of various ATP analogues to act as substrates 
for myosin light chain kinase (Table I). Myosin light chain 
kinase  is  known  to  accept  adenosine-5'-O-(3-thiotriphos- 
phate) as a substrate, but not adenylyl-imidodiphosphate or 
ADP (2). The low level of staining seen with the poor kinase 
substrates is probably due to endogenous cellular ATP, since 
a  similar level  of staining was  seen in the absence of any 
added nucleotide. 
The calcium ion concentration necessary for activation as 
assayed by antibody staining was found to be of the order of 
1 IxM (Table II). Staining was inhibited by trifluoperazine, 
at the concentrations which inhibit calmodulin-dependent 
activation of myosin light chain kinase in vitro (K~ =  6 IxM; 
reference 36). 
These results show that the amount of immunofluores- 
cence staining is  modulated by agents which alter  LC20 
phosphorylation by myosin light chain kinase. It is interest- 
ing that cAMP has no effect in this system (Table I) since in 
vitro evidence has indicated that a cAMP-dependent protein 
kinase could down-regulate myosin light chain kinase (3). In 
other experiments cGMP and tetradodecanoyl phorbol ace- 
tate (an activator of protein kinase C) were also found not to 
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inhibit myosin phosphorylation.  Neither did any of these re- 
agents cause any significant phosphorylation of LC20 as de- 
tected with the antibody when the calcium ion concentration 
was buffered  to 50  nM  (data not shown). 
The  immunofluorescence  staining  of contracted  smooth 
muscle cells appeared cytoplasmic with a periodic distribu- 
tion (Fig.  4).  In some cases this amounted to an undulating 
intensity  of staining  along  the  length  of the cell  (e.g.,  Fig. 
4,  A  and B),  while  in  others  there  appeared to be discrete 
bands.  In favorable cases  the fluorescent  staining  could be 
resolved into longitudinal elements (e.g., Fig. 4 B).  In some 
cells staining appeared concentrated towards the edge of the 
cell, though still with a banded distribution  (Fig.  4  H); this 
pattern was characteristically  observed in the shortest cells 
so that we are unable to rule out the possibility that, in these 
cells,  the density of cytoskeletal components is limiting the 
access of antibody  into the middle  region  of the cell. 
In a  number of cases the positions  of regions  containing 
Figure  2. Identification of the 
polypeptide recognized by the 
antibody  to  phosphorylated 
LC20  in  contracting  smooth 
muscle cells. A suspension of 
cells was treated with an equal 
volume of a contracting solu- 
tion (see Materials and Meth- 
ods) for 30 s and then rapidly 
boiled  in  an  SDS-containing 
sample buffer for PAGE.  The 
separated proteins were trans- 
ferred to a nitrocellulose sheet 
and  stained.  A  shows  all  the 
transferred  proteins  stained 
with Amido black; the streak- 
iness near the top of the gel is 
due to the Triton present in the 
sample.  B  is  a  similar  lane 
from the same gel which was 
stained using the affinity-purified antibody (at a protein concentra- 
tion of 80 ng/ml). The arrow indicates a band on A which migrated 
with the same mobility as purified myosin regulatory light chain 
from chicken gizzard. 
Figure  3. Antibody labeling of smooth muscle cells. A suspension 
of cells (25 gl) was applied to each well of an 8-well multitest slide 
(Flow  Laboratories) and  the cells were allowed to adhere to the 
glass for ~10  min at 20°C  in  a  humid  atmosphere.  Cells  were 
stimulated with a contracting solution (see tex0 and fixed after 30 s. 
Reactivity with the antibody was assessed by immunofluorescence. 
The cell on the left appears not to have contracted and retains the 
elongated morphology of a relaxed cell; it shows no antibody bind- 
ing.  The cell on the right has contracted normally and is labeled 
with the antibody.  (A) Phase-contrast image; (B) fluorescence im- 
age. Bar,  50 P.m. 
phosphorylated myosin correlated with bulges in the profile 
of the cell  (e.g.,  Fig.  4,  C,  G,  and H),  possibly  indicating 
that contractile elements were attached to the cell membrane 
on each side of the staining region.  The banded appearance 
was not a simple consequence of viewing a greater thickness 
of cytoplasm  and  hence  correspondingly  more  myosin  in 
those regions. The bands were still apparent when cells were 
examined  using  a  scanning  confocal  fluorescence  micro- 
scope (35) that images optical sections with a depth of only 
'~0.7  run (data not shown).  The localization  of total myosin 
(using  monoclonal  antibody  BM3)  showed  a  much  less 
marked  banding  pattern  when  it  was  examined  in  double- 
label  experiments  (Fig.  5),  indicating  that  this  pattern  is 
specifically that of phosphorylated myosin. In the case of to- 
tal myosin, the slightly nonuniform distribution  is probably 
explained  by  the  enhanced  solubility  of unphosphorylated 
myosin  (23),  which  means  that  in  the  permeabilized  cells 
used  here  myosin would  preferentially  dissociate  from the 
regions  between  bands  of phosphorylated  myosin. 
Statistical analysis (Fig. 6) indicates that the relative posi- 
tions of fluorescent bands were consistent from cell to cell. 
In spite of the  fact that the  lengths  of individual  half cells 
ranged from 15 to 125 pm, seven positions relative to the ax- 
ial  length  appeared  to  be  favored  as  locations  of  phos- 
phorylated  myosin  (Fig.  6  B).  However,  the  peaks  on  the 
histogram are not completely separated, raising the possibil- 
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phorylated  myosin  in contracting  smooth 
muscle cells, as detected using the affinity- 
purified antibody. The cells were chosen to 
illustrate  the  patterns  of  immunofluores- 
cence staining typically observed. Each cell 
is shown viewed by both phase-contrast and 
fluorescence optics, using an oil-immersion 
ity that there was a mixture of subpopulations. Further divi- 
sion of the sample showed that '~50 % of the half cells exam- 
ined  had  band  positions  which  formed  a  seven  peak 
histogram (Fig. 6 C), while a further 40% had an eight peak 
pattern (Fig. 6 D). The remaining few half cells probably had 
a  six-band pattern (data not shown). 
Discussion 
The antibody-staining pattern we observe suggests that phos- 
phorylated myosin is concentrated in a number of "contrac- 
tile zones" along the length of a contracting smooth muscle 
cell, typically 14-16 zones per cell. What might be the cellu- 
lar basis of this pattern? 
The most likely explanation is that the pattern reflects an 
underlying feature of the cytoskeleton, consistently present 
in smooth muscle cells. In Triton-permeabilized cells it can- 
not be a consequence of a spatial periodicity in the calcium 
signal, which would be uniform. Neither do we think it likely 
to be due to the distribution of myosin light chain kinase in 
the cell. Although there is no direct information on the intra- 
cellular localization of the kinase in smooth muscle cells, it 
binds to both myosin filaments and actin filaments (7,  24) 
which suggests that it will be fairly uniformly distributed, as 
it is in stress fibers of nonmuscle cells (8,  13). 
A possible explanation for the observed localization of im- 
munofluorescence in discrete zones along the cell length is 
that there are regions where myosin translocation along actin 
filaments is permitted, and others where movement is pre- 
vented. Activated myosin filaments will move with respect to 
actin, from the pointed end of an actin filament towards the 
barbed end, as long as there is no obstacle to further binding 
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Oberkochen,  FRG) NA  =  1.30. On each 
occasion, control experiments were carried 
out to ensure that no fluorescence was re- 
corded  using  the  same  photographic  ex- 
posures when the first antibody was omit- 
ted. Bar, 20 Ixm. 
of myosin heads.  Thus, phosphorylated myosin will tend to 
accumulate on the pointed-end side of such an obstacle and 
become depleted  from  the  barbed-end  side.  This  sort  of 
block to myosin translocation might exist at the dense bodies 
(4) where actin filaments attach to the cell membrane or to 
each other,  or it might be due to the presence of proteins 
which sterically hinder myosin binding. It will clearly be im- 
portant to see if the band positions correlate with a transverse 
register of other actin-binding proteins.  Although previous 
work has not suggested any obvious periodicity of ultrastruc- 
tural organization along the length of cells (4, 10, 19, 26, 28), 
it will also be interesting to reexamine contracting smooth 
muscle cells by electron microscopy. 
This is  the  first demonstration that myosin is organized 
into contractile zones in  smooth muscle cells.  There have 
been occasional reports of dense-staining bands in histologi- 
cal preparations of smooth muscle (17), although these have 
most  often  been  assumed  to  be  artefactual.  It  must  be 
stressed that in the experiments reported here, a zone pattern 
for phosphorylated myosin was not normally accompanied 
by dark bands when viewed under phase contrast. Only after 
long contraction times or in relatively acid buffers (pH <6.5) 
did we see a banding pattern in phase contrast.  At this pH 
myosin filaments are stabilized  against disassembly in the 
presence of Mg-ATP (23, 30); hence, if further translocation 
along actin filaments was blocked in certain regions, myosin 
would accumulate in unusually large concentrations at those 
locations. 
The amount of phosphorylation in  individual contractile 
zones can vary without altering the relative locations of the 
zones.  For most of the half cells analyzed in Fig.  6,  fewer 
than seven positively staining regions were scored, and yet 
Bennett et al. Localization of Phosphorylated Myosin  2627 Figure  5.  Double-label  immunofluorescence experiment to com- 
pare the distribution  of phosphorylated myosin with  that of total 
myosin in the same contracting ceils. (A) Phase-contrast image; (B) 
fluorescence  image  showing  labeling  with  antibody  to  phos- 
phorylated LC20; (C) fluorescence  image showing  labeling  with 
antibody BM3 to myosin heavy chain. Control experiments  were 
carried  out  to  ensure  that  fluorescence  due  to the  fluorescein- 
coupled second antibody was not visible with the interference filters 
used to observe rhodamine fluorescence, and vice versa. Bar, 20 ~tm. 
their positions fell into one of the patterns illustrated in Fig. 
6, C and D. Some of the seven or eight contractile zones in 
each half cell were "silent"  while the rest retained their ex- 
pected position. The inference is that the zones are mechani- 
cally coupled such that they all shorten together even when 
the myosin-based forces causing  shortening are present  in 
only some of  the zones. The structural basis of zone coupling 
can only be a  matter  for speculation  at present.  It may be 
relevant that Small's laboratory (9, 27) have demonstrated the 
presence  of longitudinal  fibrillar  domains  in  the  smooth 
muscle cell cytoskeleton that seem to have a purely mechani- 
cal function (they contain actin, filamin, and desmin, but no 
myosin).  These  are quite  distinct  from the  contractile do- 
mains which contain actin and myosin. 
It is not only in smooth muscle but also in other motile 
cells that myosin light chain phosphorylation both controls 
force generation and promotes the self-assembly of myosin 
monomers onto filaments.  We anticipate  that the  antibody 
described here will prove to be a useful tool for the localiza- 
tion of actively contractile regions of nonmuscle ceils under- 
going motile processes such as ameboid locomotion, stress 
fiber formation and breakdown,  and cytokinesis. 
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Figure 6. Analysis of the positions 
of maximum immunofluorescence 
intensity along the length of smooth 
muscle  cells.  Photographic  en- 
largements  of  contracting  ceils 
were analyzed using a microcom- 
puter with input from a digitizing 
tablet  (kindly  made available  by 
Dr. C. Stolinski,  St. Mary's Hos- 
pital  Medical  School,  London). 
For  each  cell,  a  line  was  con- 
structed  along the axis of the cell 
and the distance  of the center of 
each band from the nuclear mar- 
gin along this line was measured 
for both halves  of the cell.  The 
histograms  are plotted  as a func- 
tion of the position  of each band 
expressed  as  (A)  its  distance  in 
~tm from the nucleus,  or (B,  C, 
and D) the same distance expressed 
as a percentage  of the distance  to 
the  cell  tip.  A and  B  show  the 
complete set of 65 half cells (276 
bands),  while  C and D show se- 
lected  subpopulations  of 33  and 
26 half cells,  respectively. 
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